Category: St. Jude MedicalSyndicate content

Medtronic, Johnson & Johnson park billions in offshore accounts

June 6, 2014 by Arezu Sarvestani

Some of medtech's largest players, including Medtronic, Johnson & Johnson and Abbott, rank high on the list of companies with the most money housed in offshore tax havens, according to a new report.

J&J, Medtronic park millions in profits offshore

There are no awards handed out for companies with the most money housed in overseas accounts, but keeping cash in tax havens is its own reward for at least a dozen top medical device makers, according to a new study.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Pacemaker inventor's family's $570M suit against Boston Scientific bounces back to state court

June 6, 2014 by Brad Perriello

A federal judge sends a $570 million lawsuit filed against Boston Scientific by the family of Dr. Michel Mirowski, credited with inventing the implantable cardioverter defibrillator, back to a Maryland state court.

Pacemaker inventor's family's $570M suit against Boston Scientific bounces back to state court

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech trends: The most talked about device makers in May 2014

June 3, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

St. Jude Medical closes $455M CardioMEMS buy

June 2, 2014 by Brad Perriello

St. Jude Medical says it's complete its $455 million acquisition of CardioMEMS and its Champion HF implantable heart monitor, just days after FDA approval of the device.

St. Jude Medical closes CardioMEMS buy

St. Jude Medical (NYSE:STJ) wasted no time in closing its acquisition of CardioMEMS, days after the FDA approved the Champion HF implantable heart monitor, saying it plans to begin a "strategic" launch of the device in the U.S.

Report: New tax hasn't hurt medtech R&D | MassDevice.com On Call

May 23, 2014 by Arezu Sarvestani

A look at some of the top medical device companies suggests that the long-lamented medical device tax hasn't had much of an impact on their research & development budgets.

MassDevice.com On Call

MASSDEVICE ON CALL — Despite repeated warnings and laments, the medical device tax implemented with healthcare reform hasn't appeared to make much of a dent in the industry's research & development activities, according to a small report.

EuroPCR 2014: St. Jude touts EnligHTN data amid renal denervation backlash

May 22, 2014 by Arezu Sarvestani

St. Jude Medical says that its next-gen EnligHTN renal denervation system appears safe and effective in treating hypertension, but docs at this year's EuroPCR conference are calling for more robust clinical trials.

EuroPCR 2014: St. Jude touts EnligHTN data amid renal denervation backlash

Abbott to expand medical device footprint? | Medtech Wall Street news for the week of May 12, 2014

May 15, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott may look to expand medical device business footprint; Device makers take big writedowns on renal denervation; Cardinal Health closes $320M AccessClosure buy; K2M prices IPO under range at $132M; Allergan board spurns Valeant's $47B offer.

Abbott may look to expand medical device business footprint

May 9, 2014 by Brad Perriello

Abbott may look to expand medical device business footprint
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp